Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

MCG Partners with MultiCare to Reduce Prior Authorization Burden


MCG Health

MCG Health, part of the Hearst Health network

“Through this innovative approach, MCG can help MultiCare automate evidence-based decision-making within their existing clinical workflow.” – Jon Shreve, MCG President and CEO

MCG Health, part of the Hearst Health network and an industry leader in evidence-based guidance, announces the nation’s first implementation of a prior authorization automation solution between a payer, provider, and technology vendor using the HL7® Da Vinci Project FHIR (Fast Healthcare Interoperability Resources) standard.

MCG and MultiCare Connected Care collaborated successfully to use MCG’s interoperable application to surface and automate clinical requirements for prior authorization requests natively from electronic health records (EHR) at the point of care to payers using HL7 FHIR standards. With real-time data exchange and communications, the solution is expected to significantly reduce authorization decision times to support timely patient treatment, alleviate administrative burden for both hospitals and health plan staff, and decrease the overall costs of care delivery.

MCG and MultiCare are members of the HL7® Da Vinci Project, a national, private sector initiative to accelerate the use of HL7® FHIR to enable value-based care through interoperable data. MultiCare is utilizing the MCG Authorization application to surface transparent policy requirements and automate the retrieval of clinical data needed to establish coverage within the payer and provider workflow. MCG used the Da Vinci Implementation Guide (IG) for Documentation Templates and Rules (DTR) to accomplish the transparency and automation requirements.

“This implementation marks a new era for patient treatment and is a sterling example of successful industry collaboration,” said MCG President and CEO, Jon Shreve. “Through this innovative approach, MCG can help MultiCare automate evidence-based decision-making within their existing clinical workflow. The results of this endeavor will provide far-reaching benefits to hospitals, health plans, and most importantly, the patient.”

For more information on the MCG solution pivotal to this implementation, visit https://appmarket.epic.com/Gallery?id=13309.

###

About MCG Health

MCG, part of the Hearst Health network, provides unbiased clinical guidance that gives healthcare organizations confidence in delivering patient-centered care. MCG’s artificial intelligence and technology, infused with clinical expertise, enables its clients to prioritize and simplify their work. MCG’s world-class customer service ensures that clients maximize the benefits of licensing MCG solutions – demonstrating improved clinical and financial outcomes. For more information visit http://www.mcg.com or follow our Twitter handle at @MCG_Health.

About MultiCare Connected Care

MultiCare Connected Care (MCC) is an independent Accountable Care Organization (ACO) established in 2014 as a wholly owned subsidiary of MultiCare Health System and operates as an independent entity. It is transforming healthcare as a population health engine that represents a Clinically Integrated network (CIN) of independent & MultiCare Health System clinicians services across the entire social medical model of care. Under this entity 350,000 lives are served within 30 value based contracts.

Unlike the traditional “fee for service” health care model – where each visit, service, test and procedure has a separate cost – MCC‘s foundation is built first and foremost on providing patient centered quality care at an appropriate cost. Specific measures are used to determine how well doctors, hospitals and other providers are keeping healthy people healthy, effectively treating illnesses, and helping people better manage their chronic conditions. In this way, all the participating providers share the responsibility of providing patient centered, high quality, efficient, cost-effective care.

MCC has established a comprehensive Clinically Integrated Network (CIN) comprised of doctors and other health care providers, as well as hospitals, clinics and other health care services, such as imaging, labs and pharmacies. The CIN includes independent health care professionals in the community, as well as MultiCare employed providers totaling over 5,100 clinicians providing services across the continuum of care.

multicareconnectedcare.com

About the HL7 Da Vinci Project

As an HL7 FHIR Accelerator, the Da Vinci Project is a private sector initiative comprised of industry leaders and health information technology technical experts who are working together to accelerate the adoption of HL7® FHIR® as the standard to support and integrate value-based care (VBC) data exchange across communities. The Da Vinci Project focuses on minimizing the development and deployment of one-off solutions between partners with a goal to help all clinicians and health plans to better deliver clinical quality, value and care management outcomes. The core focus of phase one of the project is to deliver implementation guides and reference software implementations to the public for data exchange and workflows necessary to support providers and payers entering and managing VBC contracts and relationships. To learn more about the Da Vinci Project, visit https://confluence.hl7.org/display/DVP/Da+Vinci+Welcome.

About Hearst Health

The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Care guidance from Hearst Health reaches the majority of people in the U.S. The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase and MHK (formerly MedHOK). Hearst also holds a minority interest in the precision medicine and oncology analytics company M2Gen. Follow Hearst Health on Twitter @HearstHealth and LinkedIn @Hearst-Health.

Share article on social media or email:



Essex County Pediatric Cardiologist, Dr. Donald Putman Awarded NJ Top Doc


Dr. Donald Putman

Dr. Donald Putman

NJ Top Docs has reviewed and selected Donald Putman, MD for 2022. Dr. Putman is a board certified cardiologist with RWJBarnabas Health Medical Group in Livingston, New Jersey.

“As a pediatric cardiologist dedicated to my patients, I take pride in not just the care of my patients but availability and rapid responsiveness to my colleagues and referring physicians,” says Dr. Putman.

Dr. Putman is Division Chief of Pediatric Cardiology at Cooperman Barnabas Medical Center in Livingston and Director of Cardiac Screening for the Matthew J. Morahan lll Health Assessment Center.

Dr. Putman offers pediatric cardiology consultations for fetal echocardiography, congenital heart disease and suspected acquired heart disease in infants, children, adolescents and young adults.

He is continually recognized for delivering exemplary care with an upbeat engaging approach.

To learn more about NJ Top Doc Dr. Donald Putman please visit: https://njtopdocs.com/nj-doctors/metropediatriccardiologynj/

About Us

NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, please click here to contact us or visit http://www.NJTopDocs.com.

You can also follow us on Facebook, Twitter, & Instagram.

Share article on social media or email:



PDUFA and BsUFA Reauthorization Developments Webinar on Nov. 8, 2022


PDUFA and BsUFA Reauthorization Developments

What Regulatory, Compliance, and Quality Professionals Need to Know

Tuesday, Nov. 8, 2022, 1:30 p.m.–3:00 p.m. EST

https://wcg.swoogo.com/pdufa-and-bsufa

After challenging debates, Congress passed a bare-bones reauthorization of the prescription drug and biosimilars user fee programs.

What does this package contain? What did Congress leave out? What does the future hold for the accelerated approval and clinical trial diversity drug- and biologic-related riders? What does this mean for biosimilar interchangeability?

Jessica Greenbaum, counsel in King & Spalding’s FDA and Life Sciences practice and former regulatory counsel in the FDA’s Office of Therapeutic Biologics and Biosimilars, will walk attendees through the potential fate of the remaining provisions so they will be ready when, or if, the initiatives take effect.

Ms. Greenbaum will provide:


  • An overview of the bare-bones user fee package Congress enacted on Sept. 30, 2022
  • A deeper understanding of the key drug- and biologics-related riders that accompanied the original House and Senate bills, including those related to accelerated approval and diversity in clinical trials
  • Insight into the potential consequences and impacts of these provisions, including how the proposal to amend the first interchangeable exclusivity provisions could facilitate competition
  • A look at what the future holds, with congressional debate only deferred, not canceled

Congress has only two months to revive and resolve these issues before new legislators, take their seats in January. Now is the time to prepare for the inevitable changes.

Webinar Details

PDUFA and BsUFA Reauthorization Developments

What Regulatory, Compliance and Quality Professionals Need to Know

Tuesday, Nov. 8, 2022, 1:30 p.m.–3:00 p.m. EST

https://wcg.swoogo.com/pdufa-and-bsufa

Price:

$287

Easy Ways to Order:

Online: https://wcg.swoogo.com/pdufa-and-bsufa

By phone: 888.838.5578 or 703.538.7600

About WCG FDAnews:

WCG FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on WCG FDAnews’ newsletters, books, databases, webinars and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations. Learn more at fdanews.com.

Share article on social media or email:

Joseph Simone Says Medical Real Estate Developers Should Locate Properties With Equity In Mind


Montefiore Hospital’s 11-floor, 280,000-square-foot ambulatory care center at Simone’s Hutchinson Metro Center.

“Proximity to mass transit stations and bus lines are essential to creating an inclusive healthcare industry,” said Joe Simone, President of Simone Development Companies.

Joseph Simone of Simone Development Companies says that medical real estate developers should choose locations accessible to a broad range of income levels to promote healthcare inclusion.

“The site-location process should consider accessibility for low-income, as well as handicapped individuals who rely on public transportation. Proximity to mass transit stations and bus lines are essential to creating an inclusive healthcare industry,” said Joe Simone, President of Simone Development Companies.

Mass-transit-reliant consumers will gain increasing healthcare options as the Metro-North Railroad opens new train stations in the Bronx. Simone Development Companies’ Hutchinson Metro Center sits next to a future Metro-North train station in Morris Park that will provide easy access from the Hell Gate and New Haven train lines.

Some of the neighborhoods near the future rail stations have large populations of medically underserved communities. According to a New York City Community Health Profile, the neighborhood surrounding the future Hunts Point Metro-North station ranks first in New York City for adults who forego needed medical care.

The Hutchinson Metro Center’s 42-acre campus is anchored by Montefiore Hospital’s 11-floor, 280,000-square-foot ambulatory care center. The patient-focused and highly streamlined facility offers more than two dozen adult and pediatric medical specialties, including cardiology, urology, and diabetes.

“The Hutchinson Metro Center is helping to deliver healthcare equity to the Bronx and surrounding communities. Simone Development Companies will continue developing this campus to optimally serve the healthcare needs of all Bronx residents,” said Patricia Simone, principal and president of the Simone Management Group.

Simone Development Companies is a full-service real estate investment company specializing in the acquisition and development of healthcare, mixed-use, office, industrial, retail, and residential properties. Headquartered at the Hutchinson Metro Center, it boasts a portfolio of over 7 million square feet throughout the Bronx, Manhattan, Queens, Long Island, Westchester County, Orange and Fairfield Counties and New Jersey. With services spanning acquisition, development, construction, finance, asset management, accounting, leasing and property management, Simone Development Companies is set apart by its vertically integrated management team, long-term asset ownership and its pursuit of visionary development.

Share article on social media or email:

Foria Announces New Executive Team To Lead Brand Growth


This week, Jon Brandon, CEO & Co-Founder of plant-based sexual wellness company Foria, is excited to introduce a new executive team, strategically assembled to fuel the next phase of the company’s growth. Foria welcomes Liz Dolinski as Chief Marketing Officer who will work alongside Gemma DePalma (newly promoted to Chief Operating Officer).

The new executive team will lead the brand’s next chapter of national and international growth through a dynamic omnichannel strategy that includes both e-commerce and wholesale. They’ll also oversee innovation, product development, internal company evolution, strategic partnerships, and more.

As CMO, Liz Dolinski will lead Foria’s go-to-market strategy, including brand vision, creative direction, and content, as well as wholesale and direct-to-consumer streams. A seasoned marketing executive, Liz has led multiple emerging brands in making the leap from startup to fully scaled company. Prior to Foria, Liz was Chief Growth Officer at the DTC sleepwear brand Lunya, where she was responsible for all revenue-driving departments. Liz joined Foria based on her belief that the brand’s products provide life-changing experiences for its customers –– she brings a wealth of experience across marketing strategy, ecommerce, advertising, retail marketing, partner marketing, budgets, contracting, and more.

Additionally, Gemma DePalma has been promoted to Chief Operating Officer. She joined the Foria team in 2019 as Chief Supply Chain Officer, managing and maintaining executive leadership over the full supply chain team. In her new COO role, Gemma will be responsible for designing and implementing policies to promote company culture and vision. She will harness her expertise and deep understanding of Foria’s values to achieve its ambitious goals while maintaining the brand’s commitment to clean ingredients, sustainable packaging, and accessible education.

Kiana Reeves, who has been integral to Foria’s success over the past five years, will shift to Chief Content Officer. A somatic sex educator, certified sexological bodyworker, pelvic health practitioner and certified doula, Reeves has been practicing in the field of sexual wellness and female reproductive health for over 10 years and has a lifelong passion for sexual wellness and plant-based medicine. Her commitment to promoting open dialogue around pleasure and helping people feel more connected to their own sexual experiences and their bodies ultimately led her to become a voice for Foria. She harnesses her certifications and qualifications to help drive Foria’s content and brand education.

Jon is committed to building socially responsible companies that create innovative products designed to make meaningful impacts in people’s lives. That commitment led him to co-found Foria in 2014. Drawing inspiration from history’s celebration of cannabis and other plants as aids for intimacy, Jon’s drive and passion have spearheaded the creation of many of Foria’s life-changing offerings, including their bestselling Awaken arousal oil and Sex Oil. With these changes to the executive team, Jon is paving the way for Foria’s continued growth as a leader in the sexual wellness space. Discussing the new executive team, Jon shared:

“As Foria evolves into its ‘scale-up’ phase, I’m genuinely excited to be surrounded by such a talented executive team. Liz is a true scale-hacker, who brings a wealth of relevant growth expertise and Gemma is a leader who will organize our team for operational growth. These changes together with Kiana’s new focus will serve our continued mission of providing life-changing, plant-based sexual wellness products that close the pleasure gap and address the universal experiences that women and people who love them encounter across their lifespan.”

Foria’s products are available for nationwide shipping via http://www.foriawellness.com as well as at Ulta, Nordstrom, Neiman Marcus, Saks Fifth Avenue, Thrive Market and many more.

For media inquiries, please contact RVD Communications at mailto:press@foriawellness.com.

About Foria

Foria is an innovative sexual wellness company that makes life-changing, all-natural, organic formulas for intimacy, period relief and daily wellbeing. Rooted in the belief that pleasure is your nature, Foria sets the standards in the sexual wellness space for clean, innovative, and highly effective formulas. With award-winning products, Foria supports intimate experiences across every stage of life to bring more pleasure to more people.

Foria believes that pleasure and connection sit at the heart of wellbeing. Designed to fill long standing gaps in the sexual wellness market, Foria’s products are specifically designed for the female body. Guided by the wisdom of plants, Foria intentionally selects botanicals to solve real needs and deliver meaningful results. Foria’s products are sustainably made from seed to shelf, with a commitment to organic & regeneratively farmed ingredients and low impact packaging. Every product is made domestically in the USA, with mother nature in mind every step of the way.

Foria products go through rigorous development and ingredient testing to meet a standard not often seen in the industry – and it is one of the only brands that provides transparent third-party testing reports for all of its ingredients. During this process, if any ingredient doesn’t meet Foria’s standards, it is reformulated or sourced from a different supplier. The brand also provides a Certificate of Analysis (COA) for every product they sell, furthering its commitment to the health and wellness of its community.

Most recently, as part of Foria’s mission to close the pleasure gap and make pleasure and wellness accessible to all, the brand has expanded its line to include botanical CBD-Free products, including an arousal oil with botanicals and a sensual breast oil.

###

Share article on social media or email:

Top NYC Ankle and Foot Surgeon Dr. Stuart Mogul Re-launches his Website http://www.bunion.com


“My website www.bunion.com is a terrific resource to help educate those suffering from the condition. It informs them on what bunions are, treatments and procedures that can help,” says Dr. Stuart Mogul.

Stuart Mogul DPM, FACFAS, is an internationally recognized best-in-class foot surgeon, specializing in bunion surgery, who is in private practice on NYC’s Upper East Side. Dr. Mogul is pleased to announce the relaunch of his website, http://www.bunion.com, which he designed to help those suffering from painful, unattractive bunions. Knowledge is power, and http://www.bunion.com assists those suffering from bunions take the first step in finding relief. The user-friendly website offers both current and potential patients an easy-to-navigate site that focuses on the cause of bunions and treatment options available at Dr. Mogul’s state-of-the-art practice. As one of the top-rated foot surgeons in Manhattan, he offers treatment for many foot/ankle issues in addition to bunions including hammertoes, fractures, flat foot/flat feet, corns, neuromas and sports injuries. It is important that patients seek out a surgeon like Dr. Mogul who specializes in bunion surgery, not just foot, and ankle surgery. He has the ability to figure out what is causing each individual’s particular bunion and the experience to provide the customized treatment that’s right for them.

“My website http://www.bunion.com is a terrific resource to help educate those suffering from the condition. It informs them on what bunions are, treatments and procedures that can help,” says Dr. Stuart Mogul.

More About Dr. Stuart Mogul:

Dr. Stuart Mogul is a diplomate of The American Board of Foot & Ankle Surgery and a fellow of the American College of Foot and Ankle Surgeons. He is an attending physician at Lenox Hill Hospital, Midtown Surgical Center and The Center for Specialty Care in Manhattan, New York. Dr. Mogul treats many conditions at his clinic including Achilles tendon problems, ankle sprains, ankle instability, bunions, flat feet, foot fractures, gout, hammer toe, heel pain, ingrown toenails, plantar fasciitis, tendon injuries and more. At his successful clinic, located at 1111 Park Avenue Suite 1B in New York, NY, he practices free of the limitations mandated by in-network insurance participation and offers extended time, individualized attention and empathetic expertise. For more information or to schedule a consultation with Dr. Mogul, please visit http://www.bunion.com or http://www.footsurgerycenternyc.com or call (212) 658-1917.

Share article on social media or email:

Top NYC Otolaryngologist Dr. Gregory Levitin Has Developed a Unique, Needle-Free Approach to Successful Office Balloon Sinuplasty


News Image

“By performing a balloon sinuplasty in the office setting, I can improve a patient’s symptoms by 50 to 80% within the first week with no downtime or sedation using just topical anesthesia,” says Dr. Gregory Levitin.

Dr. Gregory Levitin performs over 100 in-office balloon sinuplasty procedures every year at his New York City-based office City Sinus Care. A relatively new technology, balloon sinuplasty is a quick and effective in-office treatment alternative to traditional sinus surgery performed under local anesthetic with minimal discomfort.

Dr. Levitin has recently developed an exclusive and unique topical anesthesia protocol that has eliminated 100% of needle injections for most cases. The purpose of balloon sinuplasty treatment is to provide relief from symptoms caused by chronic sinus and nasal inflammation by opening up the sinuses and nasal passages. By utilizing his needle-free approach, Dr. Levitin offers expertise in balloon sinuplasty that is truly revolutionary. Over the last 20 years, Dr. Levitin has found that the best solution is often the least invasive and by focusing exclusively on office-based nasal and sinus procedures, Dr. Levitin has been able to completely eliminate 100% of ENT surgery from his practice.

Many of the patients that Dr. Levitin treats have been suffering for months or even years. They are functional but just don’t feel normal. Only a small percentage of patients that come in need antibiotics, but nearly all have evidence of chronic inflammation. This accumulation of inflammation in the lining of the sinuses causes the most significant changes in patients’ quality of life, including difficulty breathing, sinus headaches and congestion. Dr. Levitin’s innovative, needle-free balloon sinuplasty is ideal for patients who suffer from chronic sinusitis or recurrent sinus infections, headaches or sinus pressure, chronic nasal obstruction or congestion, isolated sphenoid or frontal sinusitis, thick mucus discharge, or a reduced sense of smell or taste.

For those suffering from chronic sinusitis pain and discomfort and looking for a long-term solution, Dr. Levitin’s needle-free balloon sinuplasty may be just the answer. Unlike conventional sinus surgery, balloon sinuplasty does not include removal of bone or tissue from the nose or cause any changes to one’s appearance. During the office procedure, the sinus passages are widened with a balloon catheter that is inserted and inflated within the narrow nasal passages and then quickly removed. Without any incisions or tissue removal, there is also less bleeding, fewer risks, less post-operative pain and a quicker recovery time than with other surgical treatments.

“By performing a balloon sinuplasty in the office setting, I can improve a patient’s symptoms by 50 to 80% within the first week with no downtime or sedation using just topical anesthesia,” says Dr. Gregory Levitin. “After just two weeks, patients breathe better, sleep better, and most importantly feel better, and can finally get back their quality of life.”

More about Dr. Gregory Levitin:

Dr. Gregory Levitin, MD, FACS is a board certified Otolaryngologist-Head and Neck Surgeon and a Fellow of the American Academy of Otolaryngology (AAO-HNS). He is also an Associate Professor in the Department of Otolaryngology at The New York Eye and Ear Infirmary and is Director of the Vascular Birthmark Center of New York. Dr. Levitin’s areas of expertise include balloon sinuplasty, acute and chronic sinus disease, allergic rhinitis, snoring and obstructive sleep disorders, and voice disorders. For more information, please call 212-784-6643 to reach his Manhattan office at Columbus Circle, 200 W. 57th Street, Suite 1410, or visit http://www.sinusitistreatmentnyc.com.

Share article on social media or email:

Movemints, LLC Hits Milestone with 15 Million Mints Shipped Globally


News Image

“Movemints help clear aligner patients seat their trays, resulting in better fit, while increasing blood flow, fighting dry mouth, and freshening breath,” said Movemints Founder and Chief Executive Officer Dr. Dave Pechersky.

Movemints, LLC Hits Milestone with 15 Million Mints Shipped Globally

Movemints Promote Optimal Tooth Movement, Increase Blood Flow and Eliminate Dry Mouth During Clear Aligner Treatment

Movemints, LLC, which is dedicated to elevating the standard of care for clear aligner patients, announced today the company has shipped more than 15 million Movemints, which are the first and only concave shaped mints designed and formulated to promote optimal tooth movement during orthodontic therapy, to customers in more than 40 countries.

Developed by Orthodontist Dr. Dave Pechersky, Movemints offer a breakthrough treatment for clear aligner patients. They enable gentle chewing, which promotes optimal tooth movement, and increase blood flow, thereby reducing discomfort. Sweetened with a therapeutic dose of xylitol, Movemints eliminate dry mouth. The patented, sugar-free mints are comprised of five ingredients – xylitol, sorbitol, natural spearmint flavoring, natural mint flavoring, and magnesium stearate. Movemints are sold to dentists, orthodontists, and directly to patients through the dentalmovemints.com website as well as Amazon.com.

“Shipping 15 million mints to customers around the globe is a major milestone for Movemints, LLC and indicates that clear aligner patients globally recognize the benefits of chewing a Movemint,” said Dr. Dave, who today serves as the company’s Chief Executive Officer. “Movemints enable treatment progress and provide comfort during orthodontic therapy. They help clear aligner patients seat their trays, resulting in better fit, while increasing blood flow, fighting dry mouth, and freshening breath. We shipped our first Movemint in May 2018, and since then, have experienced exponential growth in mint distribution volume. We look forward to continuing to make the clear aligner journey an easier one for patients worldwide.”

About Movemints

Launched in 2018, Movemints fits the lifestyle of clear aligner patients, giving them fresh breath, more comfort, and delicious progress. The patented, concave shaped mints are first and only edible accessory designed and formulated for clear aligner patients. They offer a breakthrough treatment for gentle chewing, which promotes optimal tooth movement during orthodontic therapy, and can increase blood flow, thereby reducing discomfort. Sweetened with a therapeutic dose of xylitol, Movemints eliminate dry mouth. To date, Movemints, LLC has shipped more than 15 million mints to customers in more than 40 countries. The Pittsburgh-based company continues to experience a 30% year-over-year increase in mint distribution volume and international expansion. For more information, visit http://www.dentalmovemints.com or https://www.facebook.com/movemints.

Media Contact

Stacy Wagner, stacy@theprimaveragroup.com, 650-363-3509

# # #

Share article on social media or email:

MOBI CONNECT Products, Including Caregiver Monitoring and Support, Now Available In-Store at Walmart


News Image

With the rising costs and shortages of caregivers, and elderly abuse in some unfortunate cases, we wanted to offer an affordable solution to give family members peace of mind with our complete in-home monitoring network

MOBI Technologies, Inc., dedicated to building innovative Smart Health & Wellness products that are designed around the needs of individual users with relevance to modern living, is pleased to announce that three MOBI products are now available in-store at Walmart.

Walmart will carry MOBI’s Smart Emergency Alert Button, Smart Wireless Wi-Fi Otoscope and Smart DualScan Ear + Forehead Bluetooth Thermometer in over 4,500 stores across North America while MOBI CONNECT’s full line of products are available online at Walmart.com.

Every device within the MOBI CONNECT collection can be controlled from the MOBI SMART app and displayed on your mobile device, which is available for both iOS and Android. For a complete at home clinic, MOBI’s free app enables users to monitor & track their health in one place, using MOBI’s wide range of integrated health monitoring products.

The MOBI Smart Emergency Alert Button supports “aging in place” and brings family, friends, and caregivers peace-of-mind when not on site; allowing users to create a complete in-home monitoring network to notify friends and loved ones in an instant.

MOBI offers a variety of low-cost subscriptions to fit most budgets and can be expanded with other MOBI products for a complete 360 monitoring solution if needed. With one click, caregivers near or far can be alerted, and if required, professional support can dispatch emergency services.

“With the rising costs and shortages of caregivers, and elderly abuse in some unfortunate cases, we wanted to offer an affordable solution to give family members peace of mind with our complete in-home monitoring network,” said David Naghi, CEO of MOBI Technologies. “MOBI CONNECT allows elderly parents, relatives, or those with special needs to maintain independent living with simple, sophisticated tools that keep them connected from the comfort of their homes.”

The MOBI Smart Wireless Wi-Fi Otoscope allows users to easily view, record and track their inner ear, nose and throat in High Definition to share with family and healthcare professionals to help diagnose illness or injury.

The Smart DualScan Ear + Forehead Bluetooth Thermometer offers all the features, accuracy, and reliability you would expect from MOBI, including temperature and fever management using the MOBI app. With both ear and forehead reading methods and a bright, easy-to-read backlit display, the compact DualScan Bluetooth Thermometer meets your family’s needs perfectly.

For more information on all MOBI products, visit getmobi.com

About MOBI Technologies, Inc.

MOBI Technologies, Inc. is dedicated to build innovative and quality consumer electronics that are designed around the needs of individual users with relevance to modern living.

Share article on social media or email:

Family Source Consultants Hosts Free Webinar to Help Intended Parents Navigate the Affordable Care Act


News Image

With open enrollment just around the corner, it’s important to understand what your options are for maternity coverage if you are considering pursuing a surrogacy journey this year.

The Affordable Care Act: Intended Parent Questions Answered is a free on-demand webinar designed to help navigate hopeful moms and dads understand what to expect when using an ACA insurance plan for their surrogacy journey.

As a leading authority in gestational surrogacy, Family Source Consultants takes pride in assisting their Intended Parents through the more complicated matters of surrogacy insurance and medical coverage. IPs can access the webinar at their convenience and follow up with FSC when they choose.

Hosted by FSC Chief Business Development Officer Alan Osborne, the webinar covers the most cost-effective options for surrogate maternity coverage and the advantages and disadvantages of ACA plans. It is cohosted by the founder and president of International Fertility Insurance, Jason Smith, a regular speaker on surrogacy-related options and services, and a former IP himself. IFI specializes in assisting IPs through insurance matters.

Osborne says that the concept of maternity insurance can be challenging for IPs, and many don’t know where to start.

“I speak with a lot of intended parents who are confused about what insurance options are available for their surrogate,” he says. “With open enrollment just around the corner, it’s important to understand what your options are for maternity coverage if you are considering pursuing a surrogacy journey this year.”

Over the half-hour session, Osborne and Smith introduce parents to the ACA and answer common questions. They explain why the Affordable Care Act is the most cost-effective option and the various advantages and disadvantages in relation to a surrogacy journey.

Smith gives examples of nuances within ACA in terms of exclusion, caps, deductibles, and copays, and how these contributed to the overall costs of a surrogacy arrangement. He also reminded IPs that insurance criteria and policy dates can vary between states and countries.

Intended Parents should know that the right insurance plan is crucial. Understandably, many IPs are eager to find an affordable maternity insurance solution. Purchasing an ACA insurance plan is one of the most cost-effective ways of providing surrogate maternity coverage throughout the year, especially if you’re considering a multiple-embryo transfer.

The webinar is now available for viewing on-demand at https://www.familysourceconsultants.com/about-us/media/webinars/.

Open Enrollment for 2023 runs from November 1, 2022, to January 15, 2023. Those with questions regarding surrogate maternity insurance or other matters relating to surrogacy are invited to contact Family Source Consultants.

Share article on social media or email: